Percentage of female patients aged 65 years and older who were assessed for the presence or absence of urinary incontinence within 12 months
This measure is to be submitted a minimum of once per performance period for patients seen during the performance period. This measure is appropriate for use in the ambulatory setting only and is considered a general screening measure. There is no diagnosis associated with this measure. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding.
NOTE: Patient encounters for this measure conducted via telehealth (e.g., encounters coded with GQ, GT, 95, or POS 02 modifiers) are allowable.
Measure Submission Type:
Measure data may be submitted by individual MIPS eligible clinicians, groups, or third party intermediaries. The listed denominator criteria are used to identify the intended patient population. The numerator options included in this specification are used to submit the quality actions as allowed by the measure. The quality-data codes listed do not need to be submitted by MIPS eligible clinicians, groups, or third party intermediaries that utilize this modality for submissions; however, these codes may be submitted for those third party intermediaries that utilize Medicare Part B claims data. For more information regarding Application Programming Interface (API), please refer to the Quality Payment Program (QPP) website.
All female patients aged 65 years and older with a visit during the measurement period
Denominator Criteria (Eligible Cases):
All female patients aged ≥ 65 years on date of encounter
Patient encounter during the performance period (CPT or HCPCS): 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99324, 99325, 99326, 99327, 99328, 99334, 99335, 99336, 99337, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350, G0402
Patient use of hospice services any time during the measurement period: G9693
Patients who were assessed for the presence or absence of urinary incontinence within 12 months
Urinary Incontinence – Any involuntary leakage of urine.
Performance Met: Presence or absence of urinary incontinence assessed (1090F)
Performance Not Met: Presence or absence of urinary incontinence not assessed, reason not otherwise specified (1090F with 8P)
Female patients may not volunteer information regarding incontinence, so they should be asked by their physician.
Clinical Recommendation Statements
Strategies to increase recognition and reporting of urinary incontinence (UI) are required and especially the perception that it is an inevitable consequence of aging for which little or nothing can be done. (ICI)
Patients with urinary incontinence should undergo a basic evaluation that includes a history, physical examination, measurement of post-void residual volume, and urinalysis. (ACOG) (Level C)
Health care providers should be able to initiate evaluation and treatment of UI basing their judgment on the results of history, physical examination, post-voiding residual and urinalysis. (ICI) (Grade